liver disease program (YD Life Science)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameliver disease program (YD Life Science)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYD Life Science Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYD Life Science Inc
Active IndicationsN/A
Inactive IndicationsLiver Diseases

Other Information

ATC CodeN/A
Related LinksN/A